Ureter Injury Clinical Trial
Official title:
A Phase 3 Multi-Center Efficacy Study of IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery Using the da Vinci® Surgical System With Firefly® Fluorescent Imaging
This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation.
Injury to the ureter, the duct by which urine passes from the kidney into the bladder, is a well-known and serious complication of pelvic and abdominal surgery that frequently goes unrecognized intraoperatively. This study seeks to evaluate the safety and efficacy of intravenous IS-001 injection to improve surgeon ureter visualization during robotic-assisted surgery with the da Vinci® Surgical System and Firefly® imaging. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05640115 -
Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
|
Early Phase 1 | |
Recruiting |
NCT06054880 -
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
|
Phase 4 | |
Completed |
NCT03937505 -
A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy
|
Phase 2 | |
Not yet recruiting |
NCT06448143 -
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients
|
Phase 3 | |
Completed |
NCT05769257 -
A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery
|
Phase 2 | |
Recruiting |
NCT06278753 -
Comparison of Standard Cystoscopy With Carbon Dioxide Cystoscopy
|
||
Completed |
NCT04228445 -
3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency
|
Phase 3 | |
Recruiting |
NCT06085183 -
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment
|
Phase 4 | |
Completed |
NCT03387410 -
Ureter Identification With IRDye 800BK
|
Phase 1/Phase 2 |